Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 352

1.

Vitamin E and donepezil for the treatment of mild cognitive impairment.

Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ; Alzheimer's Disease Cooperative Study Group.

N Engl J Med. 2005 Jun 9;352(23):2379-88. Epub 2005 Apr 13.

PMID:
15829527
[PubMed - indexed for MEDLINE]
Free Article
2.

Mild cognitive impairment--no benefit from vitamin E, little from donepezil.

Blacker D.

N Engl J Med. 2005 Jun 9;352(23):2439-41. Epub 2005 Apr 13. No abstract available.

PMID:
15829528
[PubMed - indexed for MEDLINE]
3.

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.

Winblad B, Kilander L, Eriksson S, Minthon L, Båtsman S, Wetterholm AL, Jansson-Blixt C, Haglund A; Severe Alzheimer's Disease Study Group.

Lancet. 2006 Apr 1;367(9516):1057-65. Erratum in: Lancet. 2006 Jun 17;367(9527):1980. Lancet. 2006 Nov 11;368(9548):1650.

PMID:
16581404
[PubMed - indexed for MEDLINE]
4.

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease--pilot study.

Prasher VP, Huxley A, Haque MS; Down syndrome Ageing Study Group.

Int J Geriatr Psychiatry. 2002 Mar;17(3):270-8.

PMID:
11921156
[PubMed - indexed for MEDLINE]
5.

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.

J Am Geriatr Soc. 2001 Dec;49(12):1590-9.

PMID:
11843990
[PubMed - indexed for MEDLINE]
6.

Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.

Johannsen P, Salmon E, Hampel H, Xu Y, Richardson S, Qvitzau S, Schindler R; AWARE Study Group.

CNS Drugs. 2006;20(4):311-25. Erratum in: CNS Drugs. 2006;20(10):866.

PMID:
16599649
[PubMed - indexed for MEDLINE]
7.

Vitamin E and donepezil for the treatment of mild cognitive impairment.

Barnes DE, Yaffe K.

N Engl J Med. 2005 Sep 1;353(9):951-2; author reply 951-2. No abstract available.

PMID:
16135844
[PubMed - indexed for MEDLINE]
Free Article
8.

Donepezil for vascular cognitive impairment.

Malouf R, Birks J.

Cochrane Database Syst Rev. 2004;(1):CD004395. Review.

PMID:
14974068
[PubMed - indexed for MEDLINE]
9.

Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial.

Salloway S, Ferris S, Kluger A, Goldman R, Griesing T, Kumar D, Richardson S; Donepezil 401 Study Group.

Neurology. 2004 Aug 24;63(4):651-7.

PMID:
15326237
[PubMed - indexed for MEDLINE]
10.

Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease.

Gauthier S, Feldman H, Hecker J, Vellas B, Emir B, Subbiah P; Donepezil MSAD Study Investigators' Group.

Curr Med Res Opin. 2002;18(6):347-54.

PMID:
12442882
[PubMed - indexed for MEDLINE]
11.

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

Rogers SL, Doody RS, Mohs RC, Friedhoff LT.

Arch Intern Med. 1998 May 11;158(9):1021-31.

PMID:
9588436
[PubMed - indexed for MEDLINE]
12.

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.

Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM; Donepezil MSAD Study Investigators Group.

Int J Geriatr Psychiatry. 2005 Jun;20(6):559-69.

PMID:
15920715
[PubMed - indexed for MEDLINE]
13.

Donepezil for dementia due to Alzheimer's disease.

Birks J, Harvey RJ.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001190. Review.

PMID:
16437430
[PubMed - indexed for MEDLINE]
14.

Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group.

Homma A, Takeda M, Imai Y, Udaka F, Hasegawa K, Kameyama M, Nishimura T.

Dement Geriatr Cogn Disord. 2000 Nov-Dec;11(6):299-313.

PMID:
11044775
[PubMed - indexed for MEDLINE]
15.
16.

Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.

Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, Takita M, Arimoto I, Koma H, Takase T, Ohbayashi T.

Dement Geriatr Cogn Disord. 2009;27(3):232-9. doi: 10.1159/000203887. Epub 2009 Feb 25.

PMID:
19246907
[PubMed - indexed for MEDLINE]
17.

Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.

Black S, Román GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R; Donepezil 307 Vascular Dementia Study Group.

Stroke. 2003 Oct;34(10):2323-30. Epub 2003 Sep 11.

PMID:
12970516
[PubMed - indexed for MEDLINE]
Free Article
18.

Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.

Fleisher AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ; Alzheimer's Disease Cooperative Study.

Neurology. 2007 May 8;68(19):1588-95. Epub 2007 Feb 7.

PMID:
17287448
[PubMed - indexed for MEDLINE]
19.

Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study.

Boada-Rovira M, Brodaty H, Cras P, Baloyannis S, Emre M, Zhang R, Bahra R; 322 Study Group.

Drugs Aging. 2004;21(1):43-53.

PMID:
14715043
[PubMed - indexed for MEDLINE]
20.

Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease.

Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R.

Drugs Aging. 2008;25(2):163-74.

PMID:
18257603
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk